Europe Dialysis Market Size to register a growth of 4.9% CAGR

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Europe Dialysis Market, published by KBV research, the Europe Dialysis Market would witness market growth of 4.9% CAGR during the forecast period (2018 – 2024).

The In-center Dialysis market would dominate the Europe Dialysis Market by End User by 2024. The Home Dialysis market is expected to witness a CAGR of 5.9% during (2018 - 2024). The In-center Dialysis market is expected to witness a CAGR of 4.5% during (2018 - 2024).

The Germany market dominated the Europe Services Market by Country in 2017. The UK market is expected to witness a CAGR of 3.1% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 4.9% during (2018 - 2024).

The Hemodialysis market dominated the France Dialysis Market by Type in 2017, and would achieve a market value of $2,965.3 million by 2024. The Peritoneal Dialysis market is expected to witness a CAGR of 6.9% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/europe-dialysis-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.